What we do

Tudor Reilly Health builds online communities in important areas of need so that those with the most personal experience can share their insights. Our vision is a healthier world based on shared experience and knowledge. Our digital healthcare platform ePatient Insights™ connects patients and carers with new treatments in development. We also work with influential media and bloggers. ePatient Insights 2013

Insights

We have developed innovative online communication tools that shed new light on old challenges. Patients and carers want to be more involved in developing new treatments. Our online communities and ePatient Insights™ platform encourage that.

Solutions

Our digital communication tools point to the most effective way to reach patients and carers online. Social media, search and credible content are combined in ways that make a real difference in patients’ lives.

Communication

Content creation is in our DNA. Our team combines decades of senior media and scientific knowledge to help communicate what is happening in the world of medical discovery.

Our services

At Tudor Reilly Health, we believe in doing one thing well. For us, that’s patient-centred experience and knowledge shared through our online communities. Healthcare is an industry we understand: the thirst for innovation, the continuing changes in the environment, the almost insurmountable challenges to deliver a new medicine and, above all, the impact on patients, carers and their families. We offer ground-breaking digital healthcare technology that brings epatients together and informs them of clinical developments.

ePatient Insights™

Our proprietary technology platform brings together the increasing availability of data online to help connect patients and carers with new drugs in development.

The insights gathered may help in several ways, for example in locating new trial centers where there is the most need from a patient and carer perspective.

An epatient, or internet patient, is a health consumer who uses the internet to gather information about a medical condition of particular interest to them.

More …

Multi-national patient outreach

Not every country is the same and digital and social networks vary widely from country to country. The team at Tudor Reilly Health are experts in accessing and understanding the potential of patient and carer networks and how to build and engage useful communities effectively.

We have a network of local partner agencies, who help to provide us with local insights.

More …

epatient recruitment

Without patients willing to take part in clinical trials of new drugs, new medicines would never be developed. We use digital, social and traditional media, as well as engagement with patient groups and professional organizations, to spread the word about how to take part in on-going trials. Recent surveys have shown that that reason most people don’t take part in clinical trials is that they don’t know how to do so.

More …

About us

Tudor Reilly Health is a digital communications agency focused on healthcare. Our vision is a healthier world based on shared experience and knowledge. We build online communities in important areas of need so that epatients with the most personal experience can share their insights.

Twitter

TudorReilly

News

Tudor Reilly Health joins Britain’s most ambitious enterprises

London, UK – 23 June 2014 Tudor Reilly Health has joined Growth Accelerator, the biggest publicly-funded growth service in Britain. Led by some of the country’s most successful growth specialists, Growth Accelerator helps the most ambitious small and medium-sized enterprises (SMEs) to achieve rapid and sustainable growth. Around 12,000 SMEs are already benefiting from Growth Accelerator [...]

More...

Blog

Years in the making, social media guidance finally released

This week, after several years of anticipation, the US FDA has finally released guidelines for how drug and medical device makers should operate in the world of social media. The guidelines are being proposed nearly five years after the medicines regulator first held a public hearing to sift through the challenges and pitfalls for pharmaceutical [...]

More...